MEDP Medpace Holdings, Inc.
Platform & Compounding FCF
A+ 94.9 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
A+ 95
  • 5yr Avg ROIC 43.2%
  • Operating Margin Trend +0.96 pp/yr

Capital Efficiency

Weight: 15%
A+ 100
  • 5yr Avg ROE 68.2%
  • 5yr Share-Count CAGR -5.9%

Growth Quality

Weight: 25%
A+ 100
  • 5yr Revenue CAGR 22.0%
  • 5yr EPS CAGR 33.5%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
A+ 93
  • 5yr FCF Margin 23.9%
  • 5yr FCF/NI Conversion 1.41x

Balance Sheet

Weight: 10%
A+ 99
  • Net Debt / EBITDA -0.43x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 7.68

Stability

Weight: 5%
C- 51
  • EPS Volatility (σ/μ) 0.86
  • Piotroski F-Score 7
  • Negative-Revenue Years (5) 0/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 4 gurus held; 2 added; 2 trimmed.

Holders
4
Avg Δ position
+6.4%
New buys
0
Full exits
0
As of Q1 2026